D. E. Shaw & Co., Inc. Albireo Pharma, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$11.67 - $27.23 $201,155 - $469,363	-17,237 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $291,650 - $499,183	17,237 New	17,237 $438,000
Q3 2019 Nov 14, 2019	SELL	$20.0 - $31.88 $144,800 - $230,811	-7,240 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $222,050 - $274,106	7,240 New	7,240 $233,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.